Antibiotic resistance poses a threat to public health, food security and economic development.
Besides the obvious benefits to human health, the antimicrobial in veterinary medicine has undoubtedly been called into question. However, their use in the growth or prevention of animals and the treatment of various infectious diseases have also gradually chosen forms of bacteria in the ecosystem.
O'Neill's recent report (2016) projects 10 million people in 2050, including 4.1 million in Africa if drastic measures are not taken to combat this development. That is, by 2050, a cumulative economic cost reaching the exorbitant sum of 100,000 billion dollars in terms of lost production. Pricing the fast like a fast decision.
This is the reason why, with the FAO and the OIE, recommended the development of national plans to fight against antimicrobial resistance (AMR), according to the approach “One health, one world, one health”. The projects are developed in the production unit (AGISAR).